1 |
Compensable occupational lung diseases in living miners and ex-miners in South Africa, 2003-2013Ndaba, Nompumelelo Angeline January 2017 (has links)
A research report submitted to the Faculty of Health Sciences, University of the
Witwatersrand, Johannesburg, in partial fulfillment of the requirements for the degree of
Master of Medicine in Community Health (Occupational Medicine)
Johannesburg, March 2017. / Introduction: The Occupational Diseases in Mines and Works Act (ODMWA) 1973 (as
amended in 2002) provides for compensation of occupational lung diseases in living and
deceased miners and ex-miners. Certification data constitute a valuable source of information
on occupational diseases in the mining industry.
Objectives: The objectives of the study were: i) To describe the extent and type of
compensable lung diseases in South African mining from 2004-2012, by commodity; ii) to
describe certification trends over 2004-2012; iii) to examine specific issues related to some of
the compensable occupational lung diseases (including service duration in coal miners with
coal workers’ pneumoconiosis by coal type, describe asbestos related diseases in women and
number of miners with exclusive diamond miners certified with mesothelioma during this
period); iv) to determine the odds of developing mesothelioma from chrysotile mining and
other associated risk factors and v)to determine time from the certification to compensation
payment, using a proportion of cases certified in 2009, 2010 and 2011 financial years.
Methods: A descriptive analysis was conducted using the Medical Bureau of Occupational
Diseases (MBOD) dataset using claims from living miners, certified from 2004 up to 2012,
certified with compensable disease, for the first three objectives. For the fourth objective, the
MBOD database was used to select diseases with considerable numbers from the 2009, 2010
and 2011 years. A ten percent sample of each disease group was selected through random
sampling using stata 12, to determine time to compensation, joined with Commission for
Compensation of Occupational Diseases (CCOD) compensation database. Stataversion 12
was used to clean and analyse data. For the fifth objective, a case control analysis was
conducted to estimate the risk of mesothelioma from miners with exclusively chrysotile
mining, using exposure data from an external database.
Results: There were67660 compensable disease certifications from 2004 to 2012 financial
years, in living current and ex-miners. Almost 62% of the certification outcomes for
compensable diseases were from tuberculosis alone, comprising of current, first and second
degree TB. First and second degree diseases with no tuberculosis comprised 27% and 1.3%
respectively. There were 6601 diseases (9.7%) certified as second-degree with tuberculosis.
The proportion of specific diseases other than tuberculosis comprised of silicosis (14%);
silico-tuberculosis (9%);obstructive airways disease (2.2%);coal workers’ pneumoconiosis
(0.5%); asbestos pleural disease (6.7%) ; asbestos interstitial disease (5.2%); mesothelioma
(0.2%); lung cancer (0.04%) and 0.1% were from other diseases.
Females contributed 3.8% to the disease burden while black miners had 92%. Twenty five
percent of the compensable diseases were from ex-miners and 49 179from active miners.
Although 63% of compensable diseases were from unknown commodity (missing), 30%
were from gold mining. The certification trends for pneumoconiosis and tuberculosis peaked
in 2008, with statistically significant trend for asbestosis (p=0.01) and silico-TB (P=0.038).
Examination of the specific issues showed no statistically significant difference between
CWP certification from anthracite and bituminous coal ranks with regards to service duration,
silicosis was certified in 544 platinum miners but none of them had exclusively platinum
mining. Asbestos related disease was certified in 2241 women, with 55.4% being pleural
disease in the first degree and none of the certified women were younger than 30 years of
age, and the average service duration was approximately seven years (mean=6.97 years, SD
6.37 years).
From the sample of 389 certified cases, 26.5% (n=103) were certified at the end of the 2012
financial years. The mean time to compensation 38 months, 36 months and 19.4 months for
2009, 2010 and 2011 financial years respectively.
The case-control analysis found no statistically significant association between chrysotile
mining and mesothelioma from univariate analysis (OR=2.0 p>0.05; 95% CI: 0.7-5.4); as
well as multivariate analysis (OR=1.5; p>0.05; 95%CI: 0.4-5.2) compared to the reference
group.
Conclusion:The burden of occupational lung diseases in living current miners and ex-miners
is high, mainly from tuberculosis during this period, irrespective of the commodity and
population group. A significant finding from this study was the significant proportion of
miners certified with pneumoconiosis with less than fifteen years of mining service. The
number of women certified during this period was mainly from asbestos related diseases, a
far lesser number of women were certified with disease from other commodities. The
findings from this study support what was reported in literature namely; unacceptably long
time to compensation; incomplete documentation of exposure history in the form of service
records and no established risk for mesothelioma from exclusive chrysotile miners. / MT2017
|
2 |
A comparison of the relative costs of continuous versus intermittent infusion of cefepime in patients with chronic pseudomonal pulmonary diseaseMavukani, Fihlani Norman 06 September 2013 (has links)
Thesis (M.Sc. (Med.) (Pharmaceutical Affairs))--University of the Witwatersrand, Faculty of Health Sciences, 2012
|
3 |
Dimensions of dyspnea in chronic obstructive pulmonary disease : a nociceptive model /Steele, Bonnie Gail. January 1991 (has links)
Thesis (Ph. D.)--University of Washington, 1991. / Vita. Includes bibliographical references (leaves [113]-123).
|
4 |
Study of the actions of vasoactive substances in the rat isolated perfused lungLal, Harbans January 1995 (has links)
No description available.
|
5 |
The role of interleukin-12 in the pathogenesis of Sendai virus-induced airway disease /Stone, Amy Elizabeth Seymour, January 2002 (has links)
Thesis (Ph. D.)--University of Florida, 2002. / Typescript. Vita. Includes bibliographical references (leaves 98-110).
|
6 |
Interstitial lung disease in polymyositis and dermatomyositis /Fathi, Maryam, January 2006 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2006. / Härtill 4 uppsatser.
|
7 |
Spouses of the chronically ill : the lived experience of wives of persons with chronic obstructive pulmonary disease /Boyle, Anne Hufschmidt. January 1997 (has links)
Thesis (Ph. D.)--University of Virginia, 1997. / Includes bibliographical references (152-164). Also available online through Digital Dissertations.
|
8 |
Interstitial lung disease in South Africans with systemic sclerosisAshmore, Philippa 17 April 2015 (has links)
A research report submitted to the Faculty of Health Sciences, University of the
Witwatersrand, in partial fulfilment of the requirements for the degree of Master of
Medicine in the branch of Internal Medicine.
Johannesburg, 2014 / BACKGROUND: Interstitial lung disease (ILD) is one of the leading causes of death
in systemic sclerosis (SSc).
PATIENTS AND METHODS: A retrospective review of case records, over 20 years,
of SSc patients attending a tertiary Connective Tissue Diseases Clinic. Comparisons
between ILD and non-ILD groups at presentation were performed in order to identify
baseline associations and predictors of ILD.
RESULTS: Of the 151 participants that met inclusion criteria, 60 (40%) had ILD. On
multivariate analysis the only three variables to remain significant were median
duration of disease (OR 1.2 (1.1-1.3); p<0.001), speckled anti-nuclear antibody
(ANA) pattern (OR 2.95 (1.22-7.15); p=0.017) and bibasal crackles (OR 5.4 (2.1-
13.5); p<0.0001).
Univariate analysis of baseline variables associated with interstitial lung
disease in systemic sclerosis.
Baseline Variable ILD (n=60) Non-ILD (n=91) OR (CI 95%) p
Bibasal crackles
(%)
28 (46.7) 10 (11.0) 7.1 (3.1-16.3) <0.0001
Diffuse disease
subtype (%)
49 (81.7) 45 (48.9)
4.6 (2.1-9.9) <0.001
Limited disease
subtype (%)
8 (13.3)
38 (41.3)
0.2 (0.1-0.5) <0.001
Anti-centromere
antibodies (%)
0 (0.0) 10 (13.0) - 0.006
Cough (%) 21 (35.0) 15 (16.5) 2.7 (1.3-5.9) 0.007
Median duration in
years (IQR)
6.1 (8.3) 4.0 (5.0) 2.2 (1.8-2.4) 0.009
Speckled ANA
pattern (%)
29 (50.9) 25 (32.5) 2.5(1.2-4.9) 0.010
Dyspnoea (%) 27 (45.0) 24 (26.4) 2.3 (1.1-4.6) 0.014
Gold mining history
(%)
5 (8.3) 1 (1.1) 8.2 (0.9-71.9) 0.037
ANA=antinuclear antibody; ILD=interstitial lung disease; IQR= interquartile range; OR=odds ratio
Additionally, dyspnoea was associated with ILD severity (p=0.008). Bibasal crackles
(p=0.014), increased plasma urea (p=0.041), and reduced serum albumin (p=0.007)
were associated with mortality in the ILD group.
CONCLUSION: Interstitial lung disease in South African SSc patients is common.
The diffuse cutaneous disease subtype appears to drive the disease process. There
should be a high index of suspicion for ILD in SSc patients presenting with a gold
mining history, dyspnoea, cough and bibasal crackles.
|
9 |
Insulin-like Growth Factor-1 (IGF-1) axis : role in development of lung fibrosisBloor, Claire Alexandra January 2000 (has links)
No description available.
|
10 |
Interleukin- 17 in models of neutrophilic lung disease /Ivanov, Stefan, January 2006 (has links)
Diss. (sammanfattning) Göteborg : Göteborgs universitet, 2006. / Härtill 3 uppsatser.
|
Page generated in 0.0194 seconds